Clinical Trials · NCT04773977
Clinical Study of IBI362 in Healthy Chinese Male Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Enrollment
- 24
- Start date
- Mar 2021
- Locations
- 1 site, China
- Primary endpoint
- Evaluate the PK parameters of IBI362 in healthy Chinese male subjects